The University of Sydney School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
The University of Sydney School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
Am J Prev Med. 2022 Oct;63(4):636-646. doi: 10.1016/j.amepre.2022.04.023. Epub 2022 Jun 7.
Community pharmacists are among the most accessible healthcare providers. Community pharmacist-led screening may facilitate the early detection of illnesses/medical risk factors, optimizing health outcomes. However, it is important to assess the acceptability of screening services to ensure uptake by key stakeholders. The aim of this review was to explore the acceptability of community pharmacist-led screening by all stakeholders (i.e., patients, pharmacists, and other healthcare professionals) and identify the methods used to evaluate the acceptability of screening.
A systematic search was conducted in Embase, MEDLINE, International Pharmaceutical Abstracts, and Scopus in April 2020 since inception. Studies that explored the acceptability of pharmacist-led screening for any risk factor/medical condition(s) within community pharmacies were included.
A total of 44 studies met the inclusion criteria. A total of 17 studies identified community pharmacies as appropriate screening locations. Seven studies reported that patients were comfortable with participating in pharmacist-led screening. Eight studies explored acceptability from the perspective of medical practitioners and other healthcare professionals, with 6 reporting high recommendation acceptance rates and/or acceptability of pharmacist-led screening. Barriers to pharmacist-led screening included time and privacy constraints, whereas adequate remuneration was considered an important enabler.
Community pharmacist-led screening appears to be acceptable to patients, pharmacists, and other healthcare professionals. However, no uniform psychometrically sound measure of acceptability was used consistently across studies, rendering comparisons difficult and showing the need for future research exploring the psychometric properties of acceptability measures. Findings, including barriers and enablers to pharmacist-led screening, are important to consider when providing screening services in community pharmacies.
社区药剂师是最容易接触到的医疗保健提供者之一。社区药剂师主导的筛查可以促进疾病/医疗风险因素的早期发现，从而优化健康结果。然而，评估筛查服务的可接受性对于确保关键利益相关者的参与非常重要。本综述的目的是探讨所有利益相关者（即患者、药剂师和其他医疗保健专业人员）对社区药剂师主导的筛查的可接受性，并确定用于评估筛查可接受性的方法。
2020 年 4 月，我们在 Embase、MEDLINE、国际药学文摘和 Scopus 中进行了系统检索，检索时间从数据库建立起。纳入了探索社区药房中任何风险因素/医疗状况的药剂师主导的筛查可接受性的研究。
共有 44 项研究符合纳入标准。共有 17 项研究认为社区药房是合适的筛查地点。有 7 项研究报告称，患者愿意参与药剂师主导的筛查。有 8 项研究从医疗从业者和其他医疗保健专业人员的角度探讨了可接受性，其中 6 项报告了较高的推荐接受率和/或对药剂师主导的筛查的可接受性。药剂师主导的筛查的障碍包括时间和隐私限制，而足够的报酬被认为是一个重要的促成因素。
社区药剂师主导的筛查似乎被患者、药剂师和其他医疗保健专业人员接受。然而，在研究中没有一致使用统一的、具有心理测量学效度的可接受性衡量标准，这使得比较变得困难，并表明需要进一步研究探索可接受性衡量标准的心理测量学特性。研究结果包括药剂师主导的筛查的障碍和促成因素，在社区药房提供筛查服务时非常重要。
